These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 21114532

  • 1. Percutaneous patent foramen ovale closure using Helex and Amplatzer devices without intraprocedural echocardiographic guidance.
    Siddiqui IF, Michaels AD.
    J Interv Cardiol; 2011 Jun; 24(3):271-7. PubMed ID: 21114532
    [Abstract] [Full Text] [Related]

  • 2. Patent foramen ovale closure without echocardiographic control: use of "standby" intracardiac ultrasound.
    Hildick-Smith D, Behan M, Haworth P, Rana B, Thomas M.
    JACC Cardiovasc Interv; 2008 Aug; 1(4):387-91. PubMed ID: 19463334
    [Abstract] [Full Text] [Related]

  • 3. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
    Aral M, Mullen M.
    Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
    [Abstract] [Full Text] [Related]

  • 4. Single centre experience with GORE-HELEX septal occluder for closure of PFO.
    Ponnuthurai FA, van Gaal WJ, Burchell A, Mitchell A, Wilson N, Ormerod O.
    Heart Lung Circ; 2009 Apr; 18(2):140-2. PubMed ID: 18294910
    [Abstract] [Full Text] [Related]

  • 5. Is routine ultrasound guidance really necessary for closure of patent foramen ovale using the Amplatzer PFO occluder?
    Fateh-Moghadam S, Steeg M, Dietz R, Bocksch W.
    Catheter Cardiovasc Interv; 2009 Feb 15; 73(3):361-6. PubMed ID: 19133676
    [Abstract] [Full Text] [Related]

  • 6. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
    Matsumura K, Gevorgyan R, Mangels D, Masoomi R, Mojadidi MK, Tobis J.
    Catheter Cardiovasc Interv; 2014 Sep 01; 84(3):455-63. PubMed ID: 24550064
    [Abstract] [Full Text] [Related]

  • 7. Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size.
    Wahl A, Tai T, Praz F, Schwerzmann M, Seiler C, Nedeltchev K, Windecker S, Mattle HP, Meier B.
    JACC Cardiovasc Interv; 2009 Feb 01; 2(2):116-23. PubMed ID: 19463412
    [Abstract] [Full Text] [Related]

  • 8. Safety and feasibility of day case patent foramen ovale (PFO) closure facilitated by intracardiac echocardiography.
    Ponnuthurai FA, van Gaal WJ, Burchell A, Mitchell AR, Wilson N, Ormerod OJ.
    Int J Cardiol; 2009 Jan 24; 131(3):438-40. PubMed ID: 18037512
    [Abstract] [Full Text] [Related]

  • 9. Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale.
    Gevorgyan Fleming R, Kumar P, West B, Noureddin N, Rusheen J, Aboulhosn J, Tobis JM.
    Catheter Cardiovasc Interv; 2020 Feb 15; 95(3):365-372. PubMed ID: 31654558
    [Abstract] [Full Text] [Related]

  • 10. Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.
    Thompson AJ, Hagler DJ, Taggart NW.
    Catheter Cardiovasc Interv; 2015 May 15; 85(6):1053-7. PubMed ID: 25380406
    [Abstract] [Full Text] [Related]

  • 11. Gore Helex septal occluder for percutaneous closure of patent foramen ovale associated with atrial septal aneurysm: short- and mid-term clinical and echocardiographic outcomes.
    Musto C, Cifarelli A, Fiorilli R, De Felice F, Parma A, Pandolfi C, Confessore P, Bernardi L, Violini R.
    J Invasive Cardiol; 2012 Oct 15; 24(10):510-4. PubMed ID: 23043034
    [Abstract] [Full Text] [Related]

  • 12. Long-term transesophageal echocardiography after patent foramen ovale closure by BioSTAR and Amplatzer patent foramen ovale occluders.
    Suligoj NC, Rojko M, Suligoj B, Zorc M, Kar S, Noc M.
    Catheter Cardiovasc Interv; 2020 Feb 15; 95(3):349-354. PubMed ID: 31131978
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.
    Varma C, Benson LN, Warr MR, Yeo E, Yip J, Jaigobin CS, Webb G, McLaughlin PR.
    Catheter Cardiovasc Interv; 2004 Aug 15; 62(4):519-25. PubMed ID: 15274165
    [Abstract] [Full Text] [Related]

  • 14. A novel system for transcatheter closure of patent foramen ovale: clinical and echocardiographic outcome comparison with other contemporary devices.
    Darsaklis K, Freixa X, Asgar A, Ibrahim R, Basmadjian A, DeGuise P, Garceau P.
    Can J Cardiol; 2014 Jun 15; 30(6):639-46. PubMed ID: 24882535
    [Abstract] [Full Text] [Related]

  • 15. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale.
    Hornung M, Bertog SC, Franke J, Id D, Taaffe M, Wunderlich N, Vaskelyte L, Hofmann I, Sievert H.
    Eur Heart J; 2013 Nov 15; 34(43):3362-9. PubMed ID: 23842846
    [Abstract] [Full Text] [Related]

  • 16. Periprocedural Outcomes of Fluoroscopy-Guided Patent Foramen Ovale Closure With Selective Use of Intracardiac Echocardiography.
    Barker M, Muthuppalaniappan AM, Abrahamyan L, Osten MD, Benson LN, Bach Y, Ma J, Abraha N, Horlick E.
    Can J Cardiol; 2020 Oct 15; 36(10):1608-1615. PubMed ID: 32610094
    [Abstract] [Full Text] [Related]

  • 17. Transcatheter PFO closure with GORE(®) septal occluder: early and mid-term clinical results.
    Butera G, Saracino A, Danna P, Sganzerla P, Chessa M, Carminati M.
    Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):944-9. PubMed ID: 23897659
    [Abstract] [Full Text] [Related]

  • 18. Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder).
    Taaffe M, Fischer E, Baranowski A, Majunke N, Heinisch C, Leetz M, Hein R, Bayard Y, Büscheck F, Reschke M, Hoffmann I, Wunderlich N, Wilson N, Sievert H.
    Am J Cardiol; 2008 May 01; 101(9):1353-8. PubMed ID: 18435971
    [Abstract] [Full Text] [Related]

  • 19. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
    Manolis AS.
    Rev Recent Clin Trials; 2017 May 01; 12(2):129-138. PubMed ID: 28356032
    [Abstract] [Full Text] [Related]

  • 20. Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale.
    Saguner AM, Wahl A, Praz F, de Marchi SF, Mattle HP, Cook S, Windecker S, Meier B.
    Catheter Cardiovasc Interv; 2011 Apr 01; 77(5):709-14. PubMed ID: 20931665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.